<code id='3C929B4426'></code><style id='3C929B4426'></style>
    • <acronym id='3C929B4426'></acronym>
      <center id='3C929B4426'><center id='3C929B4426'><tfoot id='3C929B4426'></tfoot></center><abbr id='3C929B4426'><dir id='3C929B4426'><tfoot id='3C929B4426'></tfoot><noframes id='3C929B4426'>

    • <optgroup id='3C929B4426'><strike id='3C929B4426'><sup id='3C929B4426'></sup></strike><code id='3C929B4426'></code></optgroup>
        1. <b id='3C929B4426'><label id='3C929B4426'><select id='3C929B4426'><dt id='3C929B4426'><span id='3C929B4426'></span></dt></select></label></b><u id='3C929B4426'></u>
          <i id='3C929B4426'><strike id='3C929B4426'><tt id='3C929B4426'><pre id='3C929B4426'></pre></tt></strike></i>

          entertainment

          entertainment

          author:fashion    Page View:24951
          Mayo Clinic, in Rochester, Minnesota on
          Photo by KEREM YUCEL/AFP via Getty Images

          SAN FRANCISCO — Mayo Clinic has signed Silicon Valley tech startup Cerebras as its first generative AI partner, the health system announced Monday.

          The health system — known for its cutting-edge research and willingness to partner with tech companies — will give Cerebras millions of dollars to help build technology tools based on Mayo’s trove of de-identified patient data, leaders announced at the J.P. Morgan Healthcare Conference. Mayo and Cerebras did not disclose the dollar amount, but Cerebras said it was a multimillion, multi-year contract.

          advertisement

          With roughly 380 employees, Cerebras builds and sells supercomputers specifically designed for AI applications across several industries — pitting the upstart in direct competition with the market leader Nvidia Corp. Life sciences giants including GSK have used its technology for drug discovery, and it has partnered with a health network in United Arab Emirates, but this is Cerebras’ first AI contract with a U.S. health system. The deal gives Mayo access to Cerebras’ supercomputers as well as a Cerebras team to help develop health-tuned models; Mayo will then own whatever they build.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Duchenne breakthrough therapy leaves behind pioneering families
          Duchenne breakthrough therapy leaves behind pioneering families

          DuchennemusculardystrophyDr.EdwinP.Ewing,Jr./CDCPatFurlongwassittinginherhomeofficeinMiddletown,Ohio

          read more
          Diagnostic tests are hitting their mathematical limits
          Diagnostic tests are hitting their mathematical limits

          Worriedaboutyourhealth?Youcannowavailyourselfofnoninvasivediagnosticsthatclaimtoscreenforrarebirthde

          read more
          Hollywood unions extend contract negotiations for actors
          Hollywood unions extend contract negotiations for actors

          1:36HollywoodwritersandtheirsupportersfromtheSAGAFTRAactors'unionwalkthepicketlineoutsideWarnerBrosS

          read more

          Flagship Pioneering launches a new biotech in two countries

          AdobeFlagshipPioneering,theventurecapitalfirmbehindModerna,onTuesdayunveiledanewbiotechcalledQuotien